Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerance and Acute Effects of a New HFNT Nasal Cannula on Comfort, Vital Signs, Breathing Pattern and Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD

NCT05182294 is registered in ClinicalTrials.gov with Temple University as lead sponsor.

NCT NCT05182294
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05182294 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerance and Acute Effects of a New HFNT Nasal Cannula on Comfort, Vital Signs, Breathing Pattern and Gas Exchange in Patients Hospitalized With an Acute Exacerbation of COPD
Lead sponsor
Temple University
Phase
Not applicable
Overall status
Completed
Start date
May 25, 2022
Completion date
January 31, 2023
Enrollment
14 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

copd exacerbation acute